In Vitro Fertilization Program Offers "Money Back Guarantee"
The Center for Reproductive Health (CRH) is now offering a service called the IntegraMed Shared Risk Refund Program. For one fee (excluding the cost of medications), women may attempt up to three fresh IVF cycles and three frozen embryo transfer cycles. If the patient doesnt take home a baby, 70 percent of the fee is returned (100 percent if donor eggs are used).
IVF is an assisted reproductive technique that involves stimulating the ovaries with fertility medications to make extra eggs. The eggs are then removed, fertilized with the partners sperm in a laboratory, and allowed to grow into embryos. One or two embryos are then transferred into the uterus.
The average person has difficulty affording just one chance at pregnancy through IVF, says Daniel Williams, MD, professor of obstetrics and gynecology and director of the IVF program, a partnership between UC and
Fees for IVF programs vary across the country, but the cost of one fresh and one frozen IVF cycle at the CRH is $7,800 (without medications). The Shared Risk Refund Program costs less than two cycles at the CRH for eligible patients.
Although the majority of patients will be successful with IVF treatment, the reality is that most patients need more than one cycle to be successful, Dr. Williams says. By offering this exclusive program to our patients, it allows them to optimize their chances to take home a baby. While patients do pay more upfront than they would with just one cycle, the refund guarantee helps reduce the financial stress of treatment.
CRH has clinical offices at
Tags
Related Stories
UC names Suzanne Judd, PhD, as inaugural director of new Center for Public Health
April 2, 2026
Following an extensive national search, the University of Cincinnati College of Medicine has appointed Suzanne E. Judd, PhD, as the inaugural director of its newly established Center for Public Health. Judd, a renowned epidemiologist and interdisciplinary scholar, will lead the center’s mission to transform community health through innovative research, education and strategic advocacy.
Could GLP-1s help curb the opioid crisis?
April 1, 2026
The University of Cincinnati's John Winhusen was featured in a Rolling Stone article discussing the potential for GLP-1s to treat substance abuse disorders.
A legacy that leads: Honoring a beloved physician through the future of clinical medicine
March 31, 2026
After Cohen’s passing in 2023, the Harvey D. and Janet G. Cohen Charitable Foundation was established. With the establishment of the foundation, the Cohen trustees searched for a way to create lasting impact in Janet Cohen’s hometown while recognizing the compassion and dedication of her dear friend, Dr. Rouan.